{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:04:13Z","timestamp":1790373853091,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jaci.2023.09.041","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T15:19:57Z","timestamp":1699024797000},"page":"447-460.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["IgE directly affects eosinophil migration in chronic rhinosinusitis with nasal polyps through CCR3 and predicts the efficacy of omalizumab"],"prefix":"10.1016","volume":"153","author":[{"given":"Jiaqi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshi","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0910-9884","authenticated-orcid":false,"given":"Luo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengshuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2023.09.041_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.anai.2018.02.005","article-title":"Age-related prevalence of chronic rhinosinusitis and nasal polyps and their relationships with asthma onset","volume":"120","author":"Won","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib2","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1016\/j.jaip.2021.06.037","article-title":"Prevalence and symptom burden of nasal polyps in a large Austrian population","volume":"9","author":"Campion","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2023.09.041_bib3","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1080\/03007995.2020.1815682","article-title":"Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis","volume":"36","author":"Chen","year":"2020","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaci.2023.09.041_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jamaoto.2018.4103","article-title":"Association of chronic rhinosinusitis with depression and anxiety in a nationwide insurance population","volume":"145","author":"Kim","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2023.09.041_bib5","first-page":"343","article-title":"The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life","volume":"57","author":"Khan","year":"2019","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2023.09.041_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11882-017-0690-5","article-title":"Economics of chronic rhinosinusitis","volume":"17","author":"Rudmik","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2023.09.041_bib7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaci.2022.10.010","article-title":"Endotypes of chronic rhinosinusitis based on inflammatory and remodeling factors","volume":"151","author":"Wang","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib8","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","article-title":"Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis","volume":"7","author":"Stevens","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2023.09.041_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4193\/Rhino15.271","article-title":"Cellular phenotyping of chronic rhinosinusitis with nasal polyps","volume":"54","author":"Lou","year":"2016","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2023.09.041_bib10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaci.2022.02.029","article-title":"Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps","volume":"150","author":"Bai","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib11","first-page":"261","article-title":"A retrospective study of changes of histopathology of nasal polyps in adult Chinese in central China","volume":"57","author":"Jiang","year":"2019","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2023.09.041_bib12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1159\/000513312","article-title":"Changes in clinical and histological characteristics of nasal polyps in Northern China over the past 2-3 decades","volume":"182","author":"Yu","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm0496-449","article-title":"Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia","volume":"2","author":"Garcia-Zepeda","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2023.09.041_bib14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jaci.2018.10.052","article-title":"Tipping the balance: a biased nanobody antagonist of CCR3 with potential for the treatment of eosinophilic inflammation","volume":"143","author":"Pease","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl\u00a02","key":"10.1016\/j.jaci.2023.09.041_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000350387","article-title":"Total and antigen- (fungi, mites and staphylococcal enterotoxins) specific IgEs in nasal polyps is related to local eosinophilic inflammation","volume":"161","author":"Matsuwaki","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib16","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1067\/mai.2001.112374","article-title":"Total and specific IgE in nasal polyps is related to local eosinophilic inflammation","volume":"107","author":"Bachert","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1398-9995.2010.02448.x","article-title":"Mucosal tissue polyclonal IgE is functional in response to allergen and SEB","volume":"66","author":"Zhang","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2023.09.041_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.961503","article-title":"Local immunoglobulin E in nasal polyps: role and modulation","volume":"13","author":"Shen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaip.2021.09.050","article-title":"Omalizumab-induced aspirin tolerance in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease patients is independent of atopic sensitization","volume":"10","author":"Quint","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2023.09.041_bib21","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1183\/13993003.01501-2015","article-title":"Omalizumab reduces bronchial mucosal IgE and improves lung function in non-atopic asthma","volume":"48","author":"Pillai","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2023.09.041_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1398-9995.2008.01881.x","article-title":"Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti-IgE treatment","volume":"64","author":"van Rensen","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2023.09.041_bib23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2567.1998.00418.x","article-title":"High-affinity immunoglobulin E receptor (Fc epsilon RI)-bearing eosinophils, mast cells, macrophages and Langerhans\u2019 cells in allergen-induced late-phase cutaneous reactions in atopic subjects","volume":"93","author":"Ying","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2023.09.041_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri3341","article-title":"Eosinophils: changing perspectives in health and disease","volume":"13","author":"Rosenberg","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib26","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1164\/ajrccm.153.6.8665058","article-title":"High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma","volume":"153","author":"Humbert","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2023.09.041_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1164\/ajrccm.158.1.9708106","article-title":"Increased expression of high affinity IgE (FcepsilonRI) receptor-alpha chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma","volume":"158","author":"Rajakulasingam","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2023.09.041_bib28","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0091-6749(97)70033-2","article-title":"Expression of high-affinity IgE receptors (Fc\u03b5RI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations","volume":"99","author":"Sihra","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0091-6749(00)90081-2","article-title":"Blood eosinophils from atopic donors express messenger RNA for the \u03b1, \u03b2, and \u03b3 subunits of the high-affinity IgE receptor (Fc\u03b5RI) and intracellular, but not cell surface, \u03b1 subunit protein","volume":"105","author":"Smith","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaci.2019.03.026","article-title":"Epithelium-derived cystatin SN enhances eosinophil activation and infiltration through IL-5 in patients with chronic rhinosinusitis with nasal polyps","volume":"144","author":"Yan","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib31","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaci.2005.07.007","article-title":"Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects","volume":"116","author":"Poole","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood-2009-08-237727","article-title":"Phase 1\/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia","volume":"115","author":"Byrd","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.09.041_bib33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaci.2018.05.003","article-title":"Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness","volume":"143","author":"Grozdanovic","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib35","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaci.2021.07.045","article-title":"Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study","volume":"149","author":"Gevaert","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib36","article-title":"Efficacy and safety of omalizumab in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials","volume":"11","author":"Wu","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaci.2023.09.041_bib37","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/alr.22963","article-title":"Omalizumab and quality of\u00a0life in nasal polyps: a post hoc analysis","volume":"12","author":"Han","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2023.09.041_bib38","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1159\/000514262","article-title":"Real-life experience of monoclonal antibody treatments in chronic rhinosinusitis with nasal polyposis","volume":"182","author":"Meier","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/19458924211030486","article-title":"Defining the efficacy of omalizumab in nasal polyposis: a POLYP 1 and POLYP 2 subgroup analysis","volume":"36","author":"Damask","year":"2022","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2023.09.041_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100670","article-title":"Omalizumab is effective in nasal polyposis with or without asthma, a real-life study","volume":"15","author":"Tat","year":"2022","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaci.2023.09.041_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2500\/aap.2016.37.3923","article-title":"Differential effect of omalizumab on pulmonary function in patients with allergic asthma with and without chronic rhinosinusitis","volume":"37","author":"Clavenna","year":"2016","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2023.09.041_bib42","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/all.13345","article-title":"The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change","volume":"73","author":"Ertas","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2023.09.041_bib43","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/all.12922","article-title":"Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma","volume":"71","author":"Tajiri","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2023.09.041_bib44","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/lary.20191","article-title":"Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of\u00a0eosinophilic chronic rhinosinusitis patients","volume":"119","author":"Yao","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2023.09.041_bib45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000161582","article-title":"Immunoglobulin E\u2013dependent regulation of the CCR3 chemokine receptor by interferon-gamma in atopic asthmatics","volume":"148","author":"Garcia-Vega","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10238-001-8015-2","article-title":"In\u00a0vitro interferon gamma regulation of CCR-3 mRNA expression in peripheral blood leukocytes from atopic asthmatics","volume":"1","author":"Bello","year":"2001","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jaci.2023.09.041_bib47","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1183\/09031936.00.16594000","article-title":"Stimulation of eosinophil IgE low-affinity receptor leads to increased adhesion molecule expression and cell migration","volume":"16","author":"Lantero","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2023.09.041_bib48","doi-asserted-by":"crossref","first-page":"995","DOI":"10.4049\/jimmunol.167.2.995","article-title":"Human eosinophils and human high affinity IgE receptor transgenic mouse eosinophils express low levels of high affinity IgE receptor, but release IL-10 upon receptor activation","volume":"167","author":"Kayaba","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib49","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/bjd.15924","article-title":"IgE autoreactivity in bullous pemphigoid: eosinophils and mast cells as major targets of pathogenic immune reactants","volume":"177","author":"Freire","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.09.041_bib50","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/j.1365-2222.2005.02380.x","article-title":"In chronic idiopathic urticaria autoantibodies against Fc epsilonRII\/CD23 induce histamine release via eosinophil activation","volume":"35","author":"Puccetti","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2023.09.041_bib51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0091-6749(97)70198-2","article-title":"Enhanced expression of high-affinity IgE receptor (Fc\u03b5RI) \u03b1 chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells","volume":"100","author":"Rajakulasingam","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib52","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/intimm\/10.4.395","article-title":"Molecular characterization of the low-affinity IgE receptor Fc epsilonRII\/CD23 expressed by human eosinophils","volume":"10","author":"Abdelilah","year":"1998","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib53","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1164\/rccm.201611-2234OC","article-title":"Mepolizumab attenuates airway eosinophil numbers, but not their functional phenotype, in asthma","volume":"196","author":"Kelly","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2023.09.041_bib54","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1159\/000053782","article-title":"Regulation of surface FcepsilonRI expression on human eosinophils by IL-4 and IgE","volume":"124","author":"Iikura","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2023.09.041_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European position paper on rhinosinusitis and nasal polyps, 2020.","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923013854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923013854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:45:10Z","timestamp":1758793510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674923013854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0091674923013854"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2023.09.041","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgE directly affects eosinophil migration in chronic rhinosinusitis with nasal polyps through CCR3 and predicts the efficacy of omalizumab","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2023.09.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}